J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frénais, R.
Right arrow Articles by Krempf, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frénais, R.
Right arrow Articles by Krempf, M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Journal of Lipid Research, Vol. 40, 1506-1511, August 1999
Copyright © 1999 by Lipid Research, Inc.

Original Article

Apolipoprotein A-I kinetics in heterozygous familial hypercholesterolemia: a stable isotope study

R. Frénaisa, K. Ouguerrama, C. Maugeaisa, J. S. Marchinib, P. Benlianc, J. M. Barda,d, T. Magota, and M. Krempfa,e
a Centre de Recherche en Nutrition Humaine, Groupe Métabolisme, Hôtel Dieu, Nantes, France
b Division of Clinical Nutrition, School of Medicine of Ribeirão Preto, Brazil
c Service de Biochimie, Biologie Cellulaire et Biologie Moléculaire, Hôpital Saint Antoine, Paris, France
d Faculté de Pharmacie, Laboratoire de Biochimie, Hôtel Dieu, Nantes, France
e Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition, Hôtel Dieu, Nantes, France

Correspondence to: M. Krempf

Heterozygous familial hypercholesterolemia (FH) is associated with a moderate decrease of plasma apoA-I and HDL-cholesterol levels. The aim of the study was to test the hypothesis that these abnormalities were related to an increase of HDL-apoA-I fractional catabolic rate (FCR). We performed a 14-h infusion of [5,5,5-2H3]leucine in seven control subjects and seven heterozygous FH patients (plasma total cholesterol 422 ± 27 vs. 186 ± 42 mg/dL, P < 0.001, respectively). Plasma apoA-I concentration was not changed in FH compared to controls (respectively 115 ± 18 vs. 122 ± 15 mg/dL, NS), and HDL-cholesterol level was decreased (37 ± 7 vs. 46 ± 19 mg/dL, NS). Kinetics of HDL metabolism were modeled as a single compartment as no differences were observed between HDL2 and HDL3 subclasses. Both mean apoA-I FCR and absolute production rate (APR) were increased in FH (respectively, 0.36 ± 0.14 vs. 0.22 ± 0.05 pool/d, P < 0.05, and 18.0 ± 7.7 and 11.2 ± 2.3 mg/kg/d, P < 0.05). Higher HDL-triglyceride and HDL-apoE levels were observed in patients with heterozygous FH. (Respectively 19 ± 8 vs. 8 ± 3 mg/dL, P < 0.05, and 5.3 ± 0.8 vs. 3.7 ± 0.9 mg/dL, P < 0.05).

We conclude that the catabolism of HDL-apoA-I is increased in heterozygous FH patients. However, plasma apoA-I concentration was maintained because of an increased HDL-apoA-I production rate.—Frénais, R., K. Ouguerram, C. Maugeais, J. S. Marchini, P. Benlian, J. M. Bard, T. Magot, and M. Krempf. Apolipoprotein A-I kinetics in heterozygous familial hypercholesterolemia: a stable isotope study. J. Lipid Res. 1999. 40: 1506;–1511.

Supplementary key words: heterozygous familial hypercholesterolemia, stable isotope, kinetic analysis, apo AI, HDL


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Lipid Res.Home page
R. Ramakrishnan
Studying apolipoprotein turnover with stable isotope tracers: correct analysis is by modeling enrichments
J. Lipid Res., December 1, 2006; 47(12): 2738 - 2753.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
A. Kontush and M. J. Chapman
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
Pharmacol. Rev., September 1, 2006; 58(3): 342 - 374.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
A. D. Mooradian, M. J. Haas, and N. C. W. Wong
The Effect of Select Nutrients on Serum High-Density Lipoprotein Cholesterol and Apolipoprotein A-I Levels
Endocr. Rev., February 1, 2006; 27(1): 2 - 16.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
A. Wiegman, J. Rodenburg, S. de Jongh, J. C. Defesche, H. D. Bakker, J. J.P. Kastelein, and E. J.G. Sijbrands
Family History and Cardiovascular Risk in Familial Hypercholesterolemia: Data in More Than 1000 Children
Circulation, March 25, 2003; 107(11): 1473 - 1478.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
S. Canizales-Quinteros, C. A. Aguilar-Salinas, E. Reyes-Rodriguez, L. Riba, M. Rodriguez-Torres, S. Ramirez-Jimenez, A. Huertas-Vazquez, V. Fragoso-Ontiveros, A. Zentella-Dehesa, J. L. Ventura-Gallegos, et al.
Locus on Chromosome 6p Linked to Elevated HDL Cholesterol Serum Levels and to Protection Against Premature Atherosclerosis in a Kindred With Familial Hypercholesterolemia
Circ. Res., March 21, 2003; 92(5): 569 - 576.
[Abstract] [Full Text] [PDF]

Home page
 Annals of Clinical & Laboratory ScienceHome page
G. Miltiadous, M. A. Cariolou, and M. Elisaf
HDL Cholesterol Levels in Patients with Molecularly Defined Familial Hypercholesterolemia
Ann. Clin. Lab. Sci., January 1, 2002; 32(1): 50 - 54.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.